Biopharmaceutical Industry Capability Building in India: Report from a Symposium

The biopharmaceutical industry is evolving with a shift in focus from recombinant proteins and antibodies towards more complex cell and gene therapies. To be competitive globally, biomanufacturers need to focus on aligning with global standards with regard to drug quality, reducing manufacturing fai...

Descripción completa

Detalles Bibliográficos
Autores principales: Uppal, Annu, Chakrabarti, Ranjan, Chirmule, Narendra, Rathore, Anurag, Atouf, Fouad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617546/
https://www.ncbi.nlm.nih.gov/pubmed/34849178
http://dx.doi.org/10.1007/s12247-021-09596-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617546/
https://www.ncbi.nlm.nih.gov/pubmed/34849178
http://dx.doi.org/10.1007/s12247-021-09596-9

Ejemplares similares